CCEW Charity Commission profile

PHARMA POLLUTION HUB

Registered charity 1211006 · organisation 5245328

01 Identity

Registration and reporting

Registration status
Registered
Reporting status
Submission Received
Charity type
CIO
Registered
19 November 2024
Removed
Not supplied
Financial period
19 November 2024 – 31 July 2025
Latest income
£0
Latest expenditure
£0
In administration
No
Insolvent
No
CIO
Yes

Public contact address: Bush & Co, 2 Barnfield Crescent, EXETER, EX1 1QT

Website recorded by the regulator: www.pharmapollution.org (displayed as text)

03 Official extract

Charity Annual Return History

Fin Period Start Date
19 November 2024
Fin Period End Date
31 July 2025
Ar Cycle Reference
AR25
Reporting Due Date
31 May 2026
Date Annual Return Received
12 May 2026
Date Accounts Received
12 May 2026
Total Gross Income
£0
Total Gross Expenditure
£0

04 Official extract

Charity Annual Return Parta

Latest Fin Period Submitted Ind
Yes
Fin Period Order Number
1
Ar Cycle Reference
AR25
Fin Period Start Date
19 November 2024
Fin Period End Date
31 July 2025
Ar Due Date
31 May 2026
Ar Received Date
12 May 2026
Total Gross Income
£0
Total Gross Expenditure
£0
Grant Making Is Main Activity
Yes
Count Govt Contracts
0
Count Govt Grants
£0
Charity Has Trading Subsidiary
No
Does Trustee Receive Any Benefit
No
Trustee Payments Acting As Trustee
No
Trustee Receives Payments Services
No
Trustee Receives Other Benefit
No
Trustee Resigned Employment
No
Count Volunteers
0

05 Official extract

Charity Area Of Operation

Geographic Area Type
Region
Geographic Area Description
Throughout England And Wales
Welsh Ind
No
Geographic Area Type
Country
Geographic Area Description
Northern Ireland
Parent Geographic Area Type
Continent
Parent Geographic Area Description
Europe
Welsh Ind
No
Geographic Area Type
Country
Geographic Area Description
Scotland
Parent Geographic Area Type
Continent
Parent Geographic Area Description
Europe
Welsh Ind
No

06 Official extract

Charity Classification

Classification Code
102
Classification Type
What
Classification Description
Education/training
Classification Code
302
Classification Type
How
Classification Description
Makes Grants To Organisations
Classification Code
301
Classification Type
How
Classification Description
Makes Grants To Individuals
Classification Code
306
Classification Type
How
Classification Description
Provides Services
Classification Code
117
Classification Type
What
Classification Description
Other Charitable Purposes
Classification Code
115
Classification Type
What
Classification Description
Human Rights/religious Or Racial Harmony/equality Or Diversity
Classification Code
109
Classification Type
What
Classification Description
Arts/culture/heritage/science
Classification Code
307
Classification Type
How
Classification Description
Provides Advocacy/advice/information
Classification Code
206
Classification Type
Who
Classification Description
Other Defined Groups
Classification Code
207
Classification Type
Who
Classification Description
The General Public/mankind
Classification Code
205
Classification Type
Who
Classification Description
Other Charities Or Voluntary Bodies
Classification Code
308
Classification Type
How
Classification Description
Sponsors Or Undertakes Research
Classification Code
112
Classification Type
What
Classification Description
Environment/conservation/heritage
Classification Code
101
Classification Type
What
Classification Description
General Charitable Purposes
Classification Code
113
Classification Type
What
Classification Description
Economic/community Development/employment

07 Official extract

Charity Event History

Charity Name
PHARMA POLLUTION HUB
Charity Event Order
1
Event Type
CIO registration
Date Of Event
2024-11-19T00:00:00

08 Official extract

Charity Governing Document

Governing Document Description
CIO - FOUNDATION Registered 19 Nov 2024
Charitable Objects
3.1 TO PROMOTE FOR THE BENEFIT OF THE PUBLIC THE CONSERVATION, PROTECTION AND IMPROVEMENT OF THE PHYSICAL AND NATURAL ENVIRONMENT, IN PARTICULAR WITH RELATION TO THE NEGATIVE ENVIRONMENTAL IMPACTS GENERATED ACROSS THE PHARMACEUTICAL LIFE CYCLE, AT COMMUNITY, REGIONAL, NATIONAL AND INTERNATIONAL LEVELS;3.2 TO ADVANCE THE EDUCATION OF THE PUBLIC IN MATTERS RELATING TO THE SOCIAL, ECONOMIC AND ENVIRONMENTAL SUSTAINABILITY OF PHARMACEUTICAL SUPPLY, USE AND WASTE MANAGEMENT AT COMMUNITY, REGIONAL, NATIONAL AND INTERNATIONAL LEVELS, INCLUDING THROUGH THE UNDERTAKING, COMMISSIONING AND PROMOTION OF RESEARCH, AND THE DISSEMINATION OF USEFUL RESULTS, FOR THE PUBLIC BENEFIT.